The pharma agenda: Hard days ahead
Merger, acquisition, divestiture, and licensing activity will continue in 2010 as the pharmaceutical industry works to redefine itself within the shifting healthcare landscape.
By Steven Niles

The agency agenda: Social calendar
Like their clients, healthcare advertising agencies must adapt to the many challenges bombarding the industry in what is sure to be a daunting 2010.
By Steven Niles

To the point
Change, change, change
By Christiane Truelove

14th Annual Report: Top 10 Pipelines
Caution flags on spending are likely to lower as the race to revive pipelines intensifies.
By Michael D. Christel

Half a BRIC
Brazil and Russia are quietly drawing the attention of outward-looking pharmaceutical marketers, but both countries are presenting their own spin on the usual emerging markets challenges.
By Joshua Slatko

Benefits drive market strategy in autoimmune
Complex brands in the autoimmune market are being set apart and marketed based on their unique story and secondary characteristics.
By Gina-Louise Monari



Sales & Marketing
At the very time when drug marketers are feeling the pressure to justify every dollar in their budgets, several studies are questioning the value and effectiveness of DTC advertising.
By Joshua Slatko

Business
Novartis has officially inaugurated the United States’ first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, N.C.
By Steven Niles

People on the Move
Lilly Research Laboratories is aiming to advance the company’s innovative pipeline with the hire of Jan M. Lundberg, Ph.D., as executive VP, science and technology, and president, Lilly Research Laboratories.
By Gina-Louise Monari

Ad Agency Update
Wishbone/ITP has been acquired by the digital marketing agency Rosetta and will be integrated as a separate professional focused group within Rosetta’s overall healthcare business.
By Gina-Louise Monari

Interactive & Digital Marketing
Two new iPhone apps are offering patients a faster way to find physicians.
By Joshua Slatko

FDA Focus
FDA has launched a Safe Use Initiative designed to develop targeted solutions for reducing unnecessary injuries from avoidable medication misuse, errors, and other problems.
By Steven Niles

Drug Approvals
The battle against the H1N1 influenza virus continues with approvals for a number of new vaccines.
By Gina-Louise Monari



Critical need for alliance management
In a conversation with Med Ad News, Gary Gabrielsen, VP, business development, Astellas Pharma US Inc. (us.astellas.com), provides perspective and insight on the significance of geography in deal-making; the hottest therapeutic areas in current deal-making; why it is imperative that these companies manage their strategic alliances effectively; why deployment of dedicated alliance management professionals is required to develop successful alliances; and the factors that contribute to the lack of success in pharma partnerships.
By Steven Niles

Dynamics of Russian drug marketing
Richard Pilnik, president of Quintiles Global Commercial Solutions (quintiles.com), outlines distinguishing characteristics of the Russian marketplace from a pharmaceutical marketing perspective.
By Joshua Slatko

The Russian front
Richard Pilnik, president of Quintiles Global Commercial Solutions, discusses some of the challenges of the Russian marketplace with Med Ad News.
By Joshua Slatko

Proof in the concept
For the Novartis Institutes of Biomedical, the translational research model established in 2005 may yield its first big success in ACZ885.
By Christiane Truelove